CRP can exacerbate ischemic necrosis in a complement-dependent fashion and that CRP inhibition can be a safe and effective therapy for myocardial and cerebral infarcts; this has only been demonstrated in animal models. The gene discussed is CRP; the disease is cerebral infarction.